Actilyse and Actilyse Cathflo - supply shortage

Shortage resolved

alteplase

Shortage information

The shortage affecting Actilyse and Actilyse Cathflo has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Actilyse and Actilyse Cathflo
• Supply shortage status:
  Shortage resolved
• International non-proprietary name (INN) or common name:
  alteplase
• Therapeutic area (MESH):
  Myocardial Infarction
• Pharmaceutical forms affected:
  Powder and solvent for solution for injection/infusion
• Strengths affected:
  • 10 mg (Actilyse)
  • 20 mg (Actilyse)
  • 50 mg (Actilyse)
  • 2 mg (Actilyse Cathflo)
• Availability of alternatives:
  Yes

Key dates

• First published:
  23/09/2022
• Last updated:
  11/05/2023